SARAH KUDELKO: Open Payments
NPI 1508062712 · BOARDMAN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,929 in 94 payments from 20 companies in 2025. Trend: 2023 $1,592 · 2024 $2,154 · 2025 $1,929
Food & beverage: $1,868Education: $61
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $357 |
| Janssen Biotech, Inc. | 24 | $317 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $284 |
| Novartis Pharmaceuticals Corporation | 7 | $146 |
| Organon LLC | 7 | $128 |
| Regeneron Healthcare Solutions, Inc. | 5 | $93 |
| UCB, Inc. | 3 | $91 |
| Organogenesis Inc. | 3 | $82 |
| Mayne Pharma Commercial LLC | 6 | $68 |
| Arcutis Biotherapeutics, Inc. | 4 | $66 |
Products named: TREMFYA, ILUMYA, RINVOQ, SKYRIZI, DUPIXENT, COSENTYX, Bimzelx, Zoryve.
Industry payments across OH — which companies pay providers there.
